Fasting Bioequivalence Study of Pravastatin Sodium 80 mg Tablets Versus Pravachol® 80 mg Tablets In Normal Healthy Subjects
Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare the rate and extent of absorption of pravastatin
sodium from a test formulation of Pravastatin Sodium 80 mg Tablets versus the reference
Pravachol® 80 mg Tablets under fasting conditions.
Based on the results from this study, the two 80 mg pravastatin tablet formulations
demonstrated bioequivalence under the single-dose fasting conditions.